Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BW.1.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.312ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.312ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.312ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.312NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.13.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.13.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.13.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.13.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.220ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.220ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.220ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.220NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.142ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.142ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.142ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.142NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.523ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.523ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.523ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.523NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.36.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.36.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.36.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.36.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.418ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.418ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.418ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.418NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.389ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.389ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.389ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.389NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.53ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.53ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.53NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.363ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.363ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.363ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.363NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HV.1.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HV.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.405ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used